Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 22 23 24 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-13
MorphoSys AG. (1/12/17). "Press Release: MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes". Planegg. 2017-01-12
Luxendo GmbH. (1/12/17). "Press Release: Luxendo Announces Series A Extension Bringing Total Capital Raised to €8 Million". Heidelberg. 2017-01-12
Evotec AG. (1/12/17). "Press Release: Haplogen’s Novel Antiviral Target Partnered with Evotec Published in »Nature«". Vienna, Amsterdam & Hamburg. 2017-01-12
CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. 2017-01-11
Affimed N.V.. (1/11/17). "Press Release: Affimed Provides Update on NK-Cell Immuno-Oncology Platform". Heidelberg. 2017-01-11
Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt. 2017-01-10
Genedata AG. (1/10/17). "Press Release: Genedata Partners with Crescendo Biologics on Next-generation Immuno-Oncology and ADC Programs". Basel. 2017-01-10
Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. 2017-01-10
Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. 2017-01-10
Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. 2017-01-10
Immunic AG. (1/9/17). "Press Release: Immunic Strengthens Management Team and Supervisory Board". Planegg-Martinsried. 2017-01-09
Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. 2017-01-09
Merck KGaA. (1/9/17). "Press Release: Merck and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration". Darmstadt. 2017-01-09
Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. 2017-01-09
Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. 2017-01-09
Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. 2017-01-09
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. 2017-01-09
Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. 2017-01-09
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-09
Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. 2017-01-08
Noxxon Pharma N.V.. (1/6/17). "Press Release: Half-yearly Report on the Liquidity Contract with Invest Securities". Berlin. 2017-01-06
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". 2017-01-06
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. 2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. 2017-01-05
HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. 2017-01-05
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. 2017-01-05
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. 2017-01-05
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. 2017-01-05
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. 2017-01-04
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. 2017-01-04
AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. 2017-01-04
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. 2017-01-04
Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. 2017-01-04
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. 2017-01-04
Novimmune S.A.. (1/4/17). "Press Release: Novimmune Grants Tiziana an Exclusive License to NI-1201, an anti-IL-6R Monoclonal Antibody for the Treatment of Autoimmune and Inflammatory Diseases". Geneva. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
InflaRx GmbH. (1/4/17). "Press Release: InflaRx Initiates Exploratory Phase II Trial with IFX-1, a First-in-class Anti-complement C5a Antibody, in Patients with Hidradenitis Suppurativa". Jena. 2017-01-04
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. 2017-01-04
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. 2017-01-03
SGS S.A.. (1/3/17). "Press Release: SGS Acquires Laboratoire LCA, Morocco". 2017-01-03
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. 2017-01-02
CureVac AG. (12/28/16). "Press Release: CureVac to Present at the J.P. Morgan 35th Annual Healthcare Conference 2017". Tübingen. 2016-12-28
PerkinElmer, Inc.. (12/22/16). "Press Release: PerkinElmer to Sell Medical Imaging Business to Varian Medical Systems". Waltham, MA. 2016-12-22
SGS S.A.. (12/21/16). "Press Release: SGS Acquires Laagrima, Morocco". 2016-12-21
Bruker Corporation. (12/21/16). "Press Release: Bruker Delivering 300 Hand-held Chemical Detectors to German BBK". Leipzig. 2016-12-21
Actelion Ltd.. (12/21/16). "Press Release: Actelion and Johnson & Johnson Enter into Exclusive Discussions". Allschwil. 2016-12-21
Bayer AG. (12/21/16). "Press Release: Bayer Develops Companion Diagnostic Test for Cancer Patients Together with Leica Biosystems [Not intended for U.S. and UK Media]". Leverkusen. 2016-12-21
Merck KGaA. (12/21/16). "Press Release: Metformin Products, including Glucophage Approved for Type 2 Diabetes Patients with Moderate Renal Impairment in Europe [This release is not intended for US- and UK-based media]". Darmstadt. 2016-12-21
Sygnis AG. (12/21/16). "Press Release: Sygnis AG Acquires Profitable US Life Sciences Tools Company C.B.S. Scientific for US $0.9 Million in Cash and Shares". Madrid & Heidelberg. 2016-12-21
Mologen AG. (12/21/16). "Press Release: Public Rights Offering of Convertible Bonds with Purchase Guarantee by Major Shareholder. Issue volume €4.99 million, Maturity of 8 Years [Not for United States, Australia, Canada or Japan, et al.]". Berlin. 2016-12-21
Protagen AG. (12/20/16). "Press Release: Protagen AG Successfully Joined Forces with Novartis to Support Clinical Development of a Novel Compound in an Autoimmune Indication". 2016-12-20
Pharnext S.A.. (12/20/16). "Press Release: Pharnext Completes Patient Enrollment in International Pivotal Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A". Paris. 2016-12-20
Mundipharma International Ltd.. (12/20/16). "Press Release: CHMP Announces Positive Opinion for Biosimilar Rituximab Truxima and Mundipharma Has Secured Distribution Rights". Cambridge. 2016-12-20
SGS S.A.. (12/19/16). "Press Release: SGS Acquires Control of C-Labs SA, Switzerland". 2016-12-19
Novartis AG. (12/16/16). "Press Release: Novartis Bolsters Innovative Dermatology Portfolio through Acquisition of Ziarco Group Limited". Basel. 2016-12-16
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Bruker Corporation. (12/16/16). "Press Release: Bruker Announces Acquisition of Active Spectrum Micro-ESR Business". Billerica, MA. 2016-12-16
Merck KGaA. (12/16/16). "Press Release: Merck and the European Space Agency Extend Collaboration to Foster Innovation, Digitalization". Darmstadt. 2016-12-16
Bluebird Bio, Inc.. (12/15/16). "Press Release: Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement". Cambridge, MA & Munich. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec Completes Acquisition of Cyprotex plc". Hamburg. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec and Celgene Enter into Drug Discovery Collaboration for Neurodegenerative Diseases". Hamburg. 2016-12-15
Valneva S.E.. (12/15/16). "Press Release: Valneva Confirms Closing of Private Placement in Connection with €15.2m Investment by MVM Life Science Partners". Lyon. 2016-12-15
Noxxon Pharma N.V.. (12/15/16). "Press Release: Noxxon Pharma Signs Clinical Immuno-oncology Collaboration Agreement with MSD to Study NOX-A12 Combined with Keytruda (pembrolizumab) in Pancreatic and Colorectal Cancer". Berlin. 2016-12-15
Lonza Group Ltd.. (12/15/16). "Press Release: Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel & Morristown, NJ. 2016-12-15
Univercells S.A.. (12/15/16). "Press Release: Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform". Brussels. 2016-12-15
Acousia Therapeutics GmbH. (12/14/16). "Press Release: Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss". Tübingen. 2016-12-14
Tecan Group Ltd.. (12/14/16). "Press Release: Tecan Announces Change in Management Board". Männedorf. 2016-12-14
High-Tech Gründerfonds Management GmbH. (12/14/16). "Press Release: Chinese Biotech Investor Viroad Takes Over Gilupi". 2016-12-14
Amcure GmbH. (12/14/16). "Press Release: Amcure Raises €6 Million in Series B Financing and Expands Advisory Board". Eggenstein-Leopoldshafen. 2016-12-14
AMSilk GmbH. (12/14/16). "Press Release: Biosteel Fibers from AMSilk Receive Certification for product Safety and Confirmation of Biological Degradability". Planegg. 2016-12-14
Genome Diagnostics B.V. (GenDx). (12/13/16). "Press Release: GenDx Signs Reseller Agreement with Illumina". Utrecht. 2016-12-13
Bayer AG. (12/13/16). "Press Release: Monsanto Shareowners Approve Merger with Bayer". St. Louis, MO. 2016-12-13
MorphoSys AG. (12/13/16). "Press Release: MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor". 2016-12-13
Curetis N.V.. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Protagen AG. (12/13/16). "Press Release: Protagen Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases". 2016-12-13
Carpegen GmbH. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Bayer AG. (12/12/16). "Press Release: Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing". Leverkusen, et al.. 2016-12-12
Bayer AG. (12/12/16). "Press Release: Robert LaCaze to be Executive Vice President of New Oncology Strategic Business Unit at Pharmaceuticals Division of Bayer". Leverkusen. 2016-12-12
MolMed S.p.A.. (12/12/16). "Press Release: MolMed Coordinates a CAR T-cell Immunotherapy Project Awarded a 5.9 million Euro Grant by the European Commission". Milan. 2016-12-12
Novartis AG. (12/12/16). "Press Release: Novartis Provides Update on Pegpleranib Phase III Clinical Trial Program in Patients with Neovascular Age-related Macular Degeneration (nAMD or wet AMD)". Basel. 2016-12-12
Curetis N.V.. (12/12/16). "Press Release: #investEU – Curetis Obtains EIB Debt Financing Totaling up to EUR 25 Million to Further Expand Its Diagnostic Platform". Amsterdam, Holzgerlingen & Luxembourg. 2016-12-12
Evotec AG. (12/9/16). "Press Release: Evotec and Forge Therapeutics Form Strategic »Superbug« Alliance". Hamburg. 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Opens New Agriculture and Food Testing Laboratory in South Korea". 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Probiodrug AG. (12/8/16). "Press Release: Innovative Phase II Study Design of Glutaminylcyclase Inhibitor PQ912 in Early Alzheimer’s disease". Halle (Saale). 2016-12-08
Singulex, Inc.. (12/8/16). "Press Release: Singulex and Thermo Fisher Scientific Enter into License and Supply Agreement to Bring Next Generation Immunodiagnostics to Sepsis and SIRS Diagnostics". Alameda, CA. 2016-12-08
Merck KGaA. (12/8/16). "Press Release: Merck Appoints Thomas Möller as New Head of External Communications". Darmstadt. 2016-12-08
Numares AG. (12/8/16). "Press Release: Numares AG Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia". Regensburg. 2016-12-08
TCR2 Therapeutics Inc.. (12/7/16). "Press Release: TCR2 Therapeutics Launches from Stealth Mode to Accelerate Development of Novel Cancer Immunotherapies. $44.5M Series A Financing Led by MPM Capital and F2 Ventures". Cambridge, MA. 2016-12-07
Nordic Nanovector ASA. (12/7/16). "Press Release: Nordic Nanovector – Private Placement Successfully Completed [Not for the United States of America, Canada, Japan or Australia]". Oslo. 2016-12-07
Bayer AG. (12/7/16). "Press Release: Boehringer Ingelheim Vetmedica, Inc. and Bayer Enter into Agreement for Purchase of U.S. Cydectin Product Portfolio". Shawnee, KS. 2016-12-07
Ayoxxa Biosystems GmbH. (12/7/16). "Press Release: Ayoxxa Appoints Permanent CEO". Cologne. 2016-12-07
next pagenext page 1 2 3 ... 22 23 24 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top